Collegium Pharmaceutical
#5085
Rank
$1.2B
Marketcap
United States
Country
Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph. (Co-Founder & Chairman)
Mr. Joseph J. Ciaffoni (Pres, CEO & Director)
Ms. Colleen Tupper (Exec. VP & CFO)
Summary
History
Collegium was founded in 2003 and is headquartered in Canton, Massachusetts. In 2012, Collegium completed a strategic partnership agreement with Covidien, now Mallinckrodt plc, to co-promote Xtampza® ER in the US. Xtampza ER is an oxycodone product utilizing Collegium’s patented DETERx oral abuse deterrent technology.
Mission
Vision
Key Team
Ms. Shirley R. Kuhlmann (Exec. VP, Gen. Counsel, Chief Admin. Officer & Sec.)
Mr. Scott Dreyer (Exec. VP & Chief Commercial Officer)
Dr. Richard Malamut M.D. (Exec. VP & Chief Medical Officer)
Ms. Alex Dasalla (Head of Investor Relations)
Mr. Bart J. Dunn (Exec. VP of Strategy & Corp. Devel.)
Ms. Marlo Manning (Head of HR)
Mr. Scott Sudduth (Head of Technical Operations)
Recognition and Awards
References
Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph. (Co-Founder & Chairman)
Mr. Joseph J. Ciaffoni (Pres, CEO & Director)
Ms. Colleen Tupper (Exec. VP & CFO)